{"schema_version":"secwatch.filing_event.v1","accession":"0000029644-24-000064","form_type":"8-K","ticker":"DCI","cik":"0000029644","company_name":"DONALDSON Co INC","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.503840+00:00","generated_at":"2026-06-01T06:38:17.489989+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Donaldson posts record Q3 sales $927.9M, EPS $0.92; raises FY2024 EPS guidance to $3.33-$3.39","bullets":["Q3 sales up 6.0% YoY to $927.9M; net earnings $113.5M, EPS $0.92 (+21.7% YoY).","FY2024 EPS guidance raised to $3.33-$3.39 from $3.24-$3.32; sales growth 4-6%.","Life Sciences sales surged 24.2% YoY; Aftermarket +10.9%; Off-Road -9.8%.","Gross margin 35.6% (+260 bps); operating margin 15.5% (+130 bps).","Paid $90.3M in dividends and repurchased 1.5% of shares for $114M YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0000029644-24-000064","json":"https://secwatch.observer/filing/0000029644-24-000064.json","markdown":"https://secwatch.observer/filing/0000029644-24-000064.md","text":"https://secwatch.observer/filing/0000029644-24-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/29644/000002964424000064/0000029644-24-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/29644/000002964424000064/dci-20240604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:38:17.489989+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}